Regeneron Pharmaceuticals - Company Information
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines fo...Read more
Headquarters
Contact
Linkedin
Company Size10,000+
Stock SymbolREGN
Websiteregeneron.com
TypePublic
Regeneron Pharmaceuticals Technology Stack
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Regeneron Pharmaceuticals
TreeAge
TreeAge is an advanced visual modelling application for building decision trees, Markov mo...
Regeneron Pharmaceuticals Employee Profiles
Are you looking for the decision-makers at Regeneron Pharmaceuticals? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Regeneron Pharmaceuticals’s employee details in less than 30 secs.
Sign-up for 6sense Revenue AI™ for Sales
To find emails, direct dials, and more for prospects across the web.
Sign Up TodayDownload the 6sense Chrome Extension to get verified contact data of Regeneron Pharmaceuticals employees
Install Now
Regeneron Pharmaceuticals News & Press Releases
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Regeneron Pharmaceuticals latest news, alerts and updates.
Regeneron promotes Christopher Fenimore to CFO, announces board changes
While the company added Kathryn Guarini, PhD and David P. Schenkein, MD to its board, Regeneron announced the departure of Marc Tessier-Lavigne, PhD effective September 1.
11 Sep 2023
Regeneron to acquire Decibel Therapeutics for $109 million
6 unusual side effects of medicines Regeneron Pharmaceuticals has agreed to acquire Decibel Therapeutics, a clinical- stage biotechnology company specializing in therapies to restore and improve hearing and balance, for an up-front payment of $109 million.
21 Aug 2023
Regeneron Pharmaceuticals to acquire Decibel Therapeutics in $109 million deal
Regeneron Pharmaceuticals agreed to acquire Decibel Therapeutics for $4 a share, marking a 43% premium from yesterday's closing price. The U.S. Regeneron Pharmaceuticals The Tarrytown, N.Y.-based company said the deal gives Decibel a total equity value of about $109 million based on the amount payable at closing,
10 Aug 2023
Regeneron To Acquire Decibel Therapeutics
By Dean Seal Regeneron Pharmaceuticals agreed to acquire Decibel Therapeutics for $4 a share, marking a 43% premium from yesterday's closing price.
9 Aug 2023
FAQs for Regeneron Pharmaceuticals
Explore frequently asked questions about Regeneron Pharmaceuticals’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
What is Regeneron Pharmaceuticals's official website?
The official website of Regeneron Pharmaceuticals is regeneron.com You can find their contact number, email address, and headquarters by clicking here.
How many employees are working at Regeneron Pharmaceuticals?
What industry is Regeneron Pharmaceuticals in?
What is Regeneron Pharmaceuticals's tech stack?
Where are Regeneron Pharmaceuticals's headquarters?
Get instant access to B2B contact data across the web
Sign Up Today
